You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CML in accelerated phase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

Recruiting
  • CML, Chronic Phase
  • CML, Accelerated Phase
  • HS-10382(Part 1: Dose escalation)
  • HS-10382(Part 2: Dose expansion)
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Terminated
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Jacksonville, Florida
  • +9 more
Nov 6, 2021

Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia (CML)
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

Metabolic Alternation and Clinicohematological Characteristic in

Not yet recruiting
  • CML, Chronic Phase
  • Tyrosine kinase inhibitor
  • (no location specified)
Nov 6, 2023

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Completed
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
    • Limerick, Dooradoyle, Ireland
    • +32 more
    Aug 13, 2021

    Chronic Myeloid Leukemia Trial (Asciminib)

    Available
    • Chronic Myeloid Leukemia
    • (no location specified)
    Jan 17, 2023

    Lung Cancer Trial in Palo Alto (Hypofractionated accelerated radiation therapy)

    Not yet recruiting
    • Lung Cancer
    • Hypofractionated accelerated radiation therapy
    • Palo Alto, California
      Stanford University
    Oct 11, 2023

    Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

    Withdrawn
    • Accelerated Phase MPN
    • Blast Phase MPN
    • (no location specified)
    Nov 4, 2022

    Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Acute Lymphoblastic Leukemia
    • Bordeaux, Aquitaine, France
    • +11 more
    Dec 6, 2020

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Omacetaxine mepesuccinate
    • Los Angeles, California
    • +31 more
    Nov 11, 2021

    CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

    Not yet recruiting
    • CML (Chronic Myelogenous Leukemia
    • (no location specified)
    Jul 27, 2022

    CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

    Recruiting
    • CML
    • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
    • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
      FUNDALEU
    Jun 29, 2023

    Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

    Recruiting
    • Philadelphia Chromosome
    • +4 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jun 23, 2022

    Mild Cognitive Impairment, Depression Trial in Charleston (Accelerated iTBS, Sham Comparator)

    Not yet recruiting
    • Mild Cognitive Impairment
    • Depression
    • Accelerated iTBS
    • Sham Comparator
    • Charleston, South Carolina
      Medical University of South Carolina
    Aug 7, 2023

    Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

    Completed
    Has Results
    • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
    • Loma Linda, California
    • +35 more
    Mar 25, 2021

    Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • +3 more
    • Augusta, Georgia
    • +1 more
    Jul 14, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Dec 5, 2022

    Among CP-CML Participants Initiating Dasatinib inReal Life

    Completed
    • Chronic Myeloid Leukemia
    • Non-Interventional
    • Paris, France
      Local Institution
    Jun 17, 2022

    Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 27, 2022

    CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

    Not yet recruiting
    • CML, Chronic Phase
    • Harbin, Heilongjiang, China
      Institute of Hematology and Oncology, Harbin The First Hospital
    May 5, 2022

    Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Omacetaxine mepesuccinate
    • Los Angeles, California
    • +28 more
    Dec 1, 2021